Palatin Technologies PTN
NASDAQ PTN
$5.11 -0.40 (-7.26%)
At close: Oct 23, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Return on Assets [ROA] (2011 - 2026)

Updated

Palatin Technologies (PTN) posted Return on Assets [ROA] of -77.04% for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 417.78 percentage points from -494.82% a year earlier but down 36.82 percentage points from the prior quarter.

Analysis

Palatin Technologies (PTN) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Palatin Technologies' Return on Assets [ROA] came in at -142.11%, up 104.98 percentage points from FY2025.

  • Annual Return on Assets [ROA] shows a five-year change of -145.76 percentage points (FY2021 to FY2026).
  • In prior fiscal years, Palatin Technologies' Return on Assets [ROA] was -247.08% in FY2025 (-92.73 pp), -154.36% in FY2024 (-52.37 pp), -101.99% in FY2023 (-31.95 pp) and -70.04% in FY2022 (-73.69 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -714.54% in fiscal Q2 2025 to a high of -40.22% in fiscal Q3 2026 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last four quarters, with an average year-over-year change of +66.25 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was fiscal Q2 2026, with a gain of 642.08 percentage points; the weakest was fiscal Q2 2025, with a drop of 533.87 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior fiscal quarters was -40.22% (Q3 2026), -72.45% (Q2 2026) and -83.12% (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 8.08%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 4.65%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 2.45%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 10.60%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 9.10%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 9.29%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -6.13%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 2.14%
10 Palatin Technologies 14.07 Mn -19.34 Mn - -77.04%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -77.04%
Mar 31, 2026 -40.22%
Dec 31, 2025 -72.45%
Sep 30, 2025 -83.12%
Jun 30, 2025 -494.82%
Mar 31, 2025 -579.79%
Dec 31, 2024 -714.54%
Sep 30, 2024 -464.18%
Jun 30, 2024 -281.86%
Mar 31, 2024 -195.00%
Dec 31, 2023 -180.67%
Sep 30, 2023 -145.29%
Jun 30, 2023 -109.44%
Mar 31, 2023 -122.36%
Dec 31, 2022 -119.81%
Sep 30, 2022 -117.80%
Jun 30, 2022 -90.31%
Mar 31, 2022 -61.54%
Dec 31, 2021 -55.71%
Sep 30, 2021 -42.34%
API Access

Palatin Technologies Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PTN&period=max&api_key=YOUR_API_KEY